± SD

Related by string. * : Find æ ± ½ . DVD ± RW . ¡ ± ¡ ° . ¡ ° ¡ ± . æ ± ½ è . ¡ ± . La Caà ± ada . Discount æ ± ½ . ± #V [002] . ± SEM . ¡ ¯ ¡ ± . ± ez . Nuà ± ez / s [002] . Sing . sing . SS . ss . SED . Ser . S. . SER . Ss . SING . ser . sed : D' s . S & . € ™ s . Sioux Falls SD . SIOUX FALLS SD . JD S . L' s . Ulysses S. Grant . s tate . sing Happy Birthday . + S europe . SD . By CHRISTOPHER S. * *

Related by context. Frequent words. (Click for all words.) 65 ± 64 P = .# 62 p = #.# [002] 62 p = 61 % CI #.#-#.# [006] 61 n = 61 ADAS cog 59 59 ANOVA 59 preoperatively 59 pg ml 58 IPSS 58 LVEF 58 QTc 58 confidence interval CI 58 virologic response 58 % CI #.#-#.# [002] 58 Cmax 57 DAS# [002] 57 confidence interval #.#-#.# 57 pg mL 57 fasting insulin 57 estimated glomerular filtration 57 log# 56 creatinine clearance 56 p = #.# [004] 56 mmol L 56 carotid intima media 56 kg/m2 56 Secondary endpoints 55 CD4 + cell 55 CI = 55 median PFS 55 histologic 55 leukopenia 55 preoperative 55 postoperatively 55 mg kg dose 55 virologic failure 55 nondiabetic 55 serum concentrations 55 ng mL 54 PANSS 54 Median survival 54 r = 54 g dL 54 hemoglobin concentration 54 femoral neck 54 glycated hemoglobin 54 systolic BP 54 nmol L 54 logistic regression 54 Disease Activity 54 oral glucose tolerance 54 subscales 54 T2DM 53 nonsignificant 53 PCa 53 Main Outcome Measures 53 HbA1c levels 53 statistically significant differences 53 eGFR 53 microalbuminuria 53 comorbidity 53 airflow obstruction 53 mineral density 53 evaluable 53 HRQOL 53 df = 53 statistically significant 53 mg BID 53 MMSE 53 #mg/kg [002] 52 placebo p = 52 reach statistical significance 52 ziprasidone 52 z = 52 ipsilateral 52 placebo p 52 seroconversion 52 fasting glucose levels 52 fasting glucose 52 prespecified 52 Secondary endpoints included 52 ADHD RS 52 cytogenetic response 52 echocardiographic 52 Pharmacokinetic 52 QoL 52 LUTS 51 genotypic 51 achieved statistical significance 51 undetectable viral load 51 mg dL 51 51 noninferiority 51 RECIST criteria 51 nephrectomy 51 comorbidities 51 laboratory abnormalities 51 substudy

Back to home page